Article
Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic Response
31 Oct 2017
Abstract excerpt
RATIONALE: The allergen inhalation challenge is used in clinical trials to test the efficacy of new treatments in attenuating the late-phase asthmatic response (LAR) and associated airway inflammation in subjects with allergic asthma. However, not all subjects with allergic asthma develop the LAR after allergen inhalation. Blood-based transcriptional biomarkers that can identify such individuals may help in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
